| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Dilated cardiomyopathy 1L +2 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Dilated cardiomyopathy 1L +2 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Dilated cardiomyopathy 1L +2 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Dilated cardiomyopathy 1L +2 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (missense variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (missense variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Dilated cardiomyopathy 1L +2 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Dilated cardiomyopathy 1L +2 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Dilated cardiomyopathy 1L +2 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Dilated cardiomyopathy 1L +2 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Dilated cardiomyopathy 1L +2 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Dilated cardiomyopathy 1L +2 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Dilated cardiomyopathy 1L +2 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Dilated cardiomyopathy 1L +2 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Dilated cardiomyopathy 1L +2 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Dilated cardiomyopathy 1L +2 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Autosomal recessive limb-girdle muscular dystrophy type 2F +2 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (genic upstream transcript variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Dilated cardiomyopathy 1L +2 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Dilated cardiomyopathy 1L +2 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Dilated cardiomyopathy 1L +2 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (synonymous variant +1 more) | Qualitative or quantitative defects of delta-sarcoglycan +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan | |
| | | Single nucleotide variant (intron variant) | not specified +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Qualitative or quantitative defects of delta-sarcoglycan +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant) | not specified +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (3 prime UTR variant) | Dilated cardiomyopathy 1L +3 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Dilated cardiomyopathy 1L +3 more | |
| | | Duplication (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan +2 more | |
| | | Duplication (3 prime UTR variant) | Dilated Cardiomyopathy, Dominant +3 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Limb-girdle muscular dystrophy, recessive +2 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Dilated cardiomyopathy 1L +4 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Dilated cardiomyopathy 1L +3 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (3 prime UTR variant) | Dilated cardiomyopathy 1L +3 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | not provided +4 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Dilated cardiomyopathy 1L +3 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Dilated cardiomyopathy 1L +3 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Limb-girdle muscular dystrophy, recessive +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Limb-girdle muscular dystrophy, recessive +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (3 prime UTR variant) | Dilated cardiomyopathy 1L +3 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | not provided +4 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | not provided +2 more | |
| | | Deletion (3 prime UTR variant) | Qualitative or quantitative defects of delta-sarcoglycan +2 more | |
| | | Deletion (3 prime UTR variant) | Dilated Cardiomyopathy, Dominant +3 more | |
| | | Duplication (3 prime UTR variant) | Dilated cardiomyopathy 1L +4 more | |